Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 30830216.
- Also identified by DOI 10.1001/jamainternmed.2018.7661 and PMC identifier 6450302.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study evaluates the inclusion of studies identified by the FDA as having falsified data in the results of meta-analyses.
Medical subject headings
- Clinical Trials as Topic
- Drug Approval
- Drug Evaluation
- Pyrazoles
- Pyridones
- United States Food and Drug Administration